Showing 2,018 news articles about PrEP

Filters Content type: Editors' picks Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

PrEP science

Islatravir Subdermal Implant for HIV PrEP Has Promising Phase 1 Trial

Editor's pick
Contagion Live
7 October 2021
Combatting stigma

Ending PrEP Stigma: Researcher Calls For Integrating HIV Services Into Primary Health Care

Editor's pick
TheBodyPro
4 October 2021
PrEP programmes & uptake

Is There a PrEP-to-Primary Care Pipeline?

Editor's pick
POZ
28 September 2021
Injectable & long-acting PrEP

FDA grants Priority Review to ViiV Healthcare’s New Drug Application for cabotegravir long-acting for prevention of HIV

Editor's pick
ViiV Healthcare press release
28 September 2021
PrEP programmes & uptake

Don’t Underestimate the Benefit of HIV PrEP for Trans Women

Editor's pick
POZ
22 September 2021
PrEP programmes & uptake

US: States Late to Adopt PrEP Risk Falling Further Behind

Editor's pick
American Journal of Managed Care
20 September 2021
New & experimental HIV treatments

Exavir Therapeutics announces publication of preclinical data for novel tenofovir prodrug, XVIR-210, in Nature Communications, demonstrating long-acting exposures sufficient for antiviral activity against HIV and HBV

Editor's pick
GlobeNewswire
20 September 2021
PrEP programmes & uptake

People Who Might Benefit Most From PrEP Too Often Stop Taking It. Can Targeted Strategies Help?

Editor's pick
TheBodyPro
13 September 2021
PrEP science

First-in-Class NRTTI Demonstrates Potential as Long-Acting Oral PrEP Against HIV

Editor's pick
Contagion Live
13 September 2021
Injectable & long-acting PrEP

Editorial: HIV prevention injection should be fast-tracked like COVID-19 vaccines

Editor's pick
Spotlight
12 September 2021
PrEP programmes & uptake

Access to Care is Key to PrEP Initiation, But More Is Needed to Mitigate Attrition

Editor's pick
Contagion Live
8 September 2021
PrEP science

Truvada or Descovy for PrEP? Your Lab Work May Tell You

Editor's pick
POZ
8 September 2021
Injectable & long-acting PrEP

In-depth: What will it take to bring HIV prevention injections to South Africa’s clinics?

Editor's pick
Spotlight
1 September 2021
PrEP programmes & uptake

How to speed-up PrEP rollout in sub-Saharan Africa

Editor's pick
Avert
31 August 2021
PrEP programmes & uptake

Creating Greater PrEP Access with Large Public Health Goals and Local Service Models

Editor's pick
Contagion Live (Video)
21 August 2021
PrEP programmes & uptake

PrEP: Orange Free State government spreads message in bid to curb HIV

Editor's pick
Health-E News, South Africa
21 August 2021
Condoms & lubricant

Guys Keep Ghosting Me for Wanting Responsible Sex. Has Everyone Gone Crazy?

Editor's pick
Slate
17 August 2021
PrEP programmes & uptake

With hook up culture on the rise, S.F. health officials push to get people back on PrEP

Editor's pick
San Francisco Chronicle
17 August 2021
PrEP programmes & uptake

Worsening disparities in HIV prevention between states

Editor's pick
Medical Xpress
12 August 2021
Resistance

Transmitted Drug Resistance to Tenofovir and Emtricitabine is declining in China

Editor's pick
Infectious Disease Advisor
12 August 2021
Injectable & long-acting PrEP

Kenyan Women to Take Part in Monthly HIV Pill Trial

Editor's pick
AllAfrica
12 August 2021
PrEP programmes & uptake

The Future of HIV PrEP Is Individualized, Accessible

Editor's pick
Contagion Live
12 August 2021
PrEP

Gilead Warns of Counterfeit HIV Medication Being Distributed in the United States

Editor's pick
Gilead press release
9 August 2021
PrEP science

Two PrEP medications are now available. Equally safe/effective. The biggest difference? The price tag.

Editor's pick
Medical Xpress
5 August 2021